GSK Wants 3rd Circ. To Rehear La. Flonase Decision
GlaxoSmithKline PLC on Friday asked the Third Circuit to reconsider a decision that found the state of Louisiana was not barred by a class action antitrust settlement from bringing its own...To view the full article, register now.
Already a subscriber? Click here to view full article